Regression of Liver Steatosis Following Phosphatidylcholine Administration: A Review of Molecular and Metabolic Pathways Involved

Liver steatosis is a key pathology in non-alcoholic or metabolic associated fatty liver disease. Though largely ignored for decades it is currently becoming the focus of research in hepatology. It is important to consider its origin and current opportunities in terms of pharmacotherapy. Essential ph...

Descripción completa

Detalles Bibliográficos
Autores principales: Osipova, D., Kokoreva, K., Lazebnik, L., Golovanova, E., Pavlov, Ch., Dukhanin, A., Orlova, S., Starostin, K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8960636/
https://www.ncbi.nlm.nih.gov/pubmed/35359878
http://dx.doi.org/10.3389/fphar.2022.797923

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8960636/
https://www.ncbi.nlm.nih.gov/pubmed/35359878
http://dx.doi.org/10.3389/fphar.2022.797923

Ejemplares similares